The most common adverse effects include nausea, vomiting, and diarrhoea or constipation
45% were White, 0.4% Black or African American
Safety Overall, tirzepatide was well tolerated in the SURMOUNT clinical trial program
Journal of Comparative Effectiveness Research, 14 (9), e250083
GLP-1 Considerations For Health Plans Financial Implications Like any other drug being added to CMS Formulary Reference File, health plans must consider the holistic impact of adding or not adding Wegovy to formularies
#NuclearMedicine #ProstateCancer #RPTherapy To view or add a comment, sign in Research shows that the UA alcohol ETG test only has a 24 hour detection window